Department of Cardiovascular Medicine and Surgery, University of Louvain Medical School, Brussels, Belgium.
Ann Thorac Surg. 2011 Apr;91(4):1165-8. doi: 10.1016/j.athoracsur.2010.11.073.
Selected patients, presenting for reoperative coronary surgery with patent internal thoracic arteries (ITAs), may benefit from techniques to salvage and reuse these ITA grafts. We have termed this practice the recycling of ITAs. The purpose of this study is to report our short-term and midterm results using various recycling techniques.
Between April 1996 and February 2009, 60 patients underwent ITA recycling at our institution. Information regarding survival and cardiac events was obtained from a prospectively maintained, institutional database. Survival and freedom from major adverse cardiac events were calculated using Kaplan-Meier analysis. Mean follow-up duration was 60 ± 36 months.
Mean age was 64 ± 9 years and the mean time to reoperation was 117 ± 68 months. The patent ITA served as an inflow for a composite Y graft in 39 patients and was distally reimplanted on the same coronary vessel in 9 patients. A combination of these two techniques was used in 8 patients. Other techniques were used in the remaining 4 patients. Freedom from cardiac death was 93% ± 7% and 85% ± 9% at 1 and 5 years and freedom from major adverse cardiac events was 93% ± 7% and 81% ± 11% at 1 and 5 years, respectively.
Recycling of ITA grafts during reoperative coronary artery bypass grafting is safe and feasible in selected patients. These techniques can be useful in selected young patients to avoid saphenous vein graft or in patients with a lack of graft conduits.
对于有通畅的内乳动脉(ITA)的再次行冠状动脉旁路移植术(CABG)的患者,某些技术可能有助于回收和再次利用这些 ITA 移植物。我们将这种做法称为 ITA 再循环。本研究旨在报告我们使用各种再循环技术的短期和中期结果。
1996 年 4 月至 2009 年 2 月期间,我们医院有 60 名患者接受了 ITA 再循环。通过一个前瞻性维护的机构数据库获得有关生存和心脏事件的信息。使用 Kaplan-Meier 分析计算生存和无重大不良心脏事件的发生率。平均随访时间为 60 ± 36 个月。
平均年龄为 64 ± 9 岁,再次手术的平均时间为 117 ± 68 个月。39 名患者的通畅 ITA 用作复合 Y 移植物的流入,9 名患者的 ITA 远端再植入同一冠状动脉。8 名患者采用这两种技术的联合。其余 4 名患者采用了其他技术。无心脏死亡的 1 年和 5 年生存率分别为 93% ± 7%和 85% ± 9%,无重大不良心脏事件的 1 年和 5 年生存率分别为 93% ± 7%和 81% ± 11%。
在再次行 CABG 时,ITA 移植物的再循环在选定的患者中是安全可行的。这些技术在某些年轻患者中可以避免使用大隐静脉移植物,或在缺乏移植物管道的患者中可以使用。